Skip to main content
SpringerLink
Log in

The Interferons

  • Chapter
Immunotherapy of Disease

Part of the book series: Immunology and Medicine Series ((IMME,volume 14))

Abstract

lnteferon (IFN) was originally discovered as an antiviral protein1, but it subsequently became clear that there are several types of interferon and that they have wide biological properties extending far beyond antiviral effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lindemann, J., Burke, D. and Isaacs, A. (1957). Studies of the production, mode of action and properties of interferon. Br. J. Exp. Pathol., 38, 551–62

    Google Scholar 

  2. Intcferon nomenclature (1980). Nature. 286, 110

    Google Scholar 

  3. Cantell, K. (1981). Interferon I, 2, ( New York: Academic Press )

    Google Scholar 

  4. Pestka, S. (1986). Interferon: A decade of accomplishments, foundations of the future in research and therapy. Semin. Haematol., 23, (3, Suppl. 1), 27–37

    CAS  Google Scholar 

  5. Morris, A. and Ward, G. (1987). Production of recombinant interferons by expression in heterologous mammalian cells. In Clemens. M., Morris, A. and Gearing. A. (eds.) Lymphokines and Interferons: a Practical Approach, ( Oxford: IRL Press )

    Google Scholar 

  6. Glasgow, L. A. (1966). Enhanced interferon response of leukocytes from immune animals. J. Immunol., 91, 2185–91

    CAS  Google Scholar 

  7. Chang, T., Testa, D., Kung, P. C., Perry. L., Dreskin, H. J. and Goldstein, G. (1982). Cellular origin and interactions involved in gamma-interferon production induced by OKT3 monoclonal antibody. J. Immunol., 128. 585–9

    PubMed  CAS  Google Scholar 

  8. Masako, M., Kazuo, S., Yashimi, K. and Yorio. H. (1982). Production of immune interferon by human cytotoxic T cell clones. J. Immunol. 129. 450–5

    Google Scholar 

  9. Ortaldo, J. R., Mason. A. T., Gerard. J. P., Henderson, L. E., Farrar, W., Hopkins, R. F., Herberman, R. B. and Rabin, H. (1984). Effects of natural and recombinant IL,-2 on the regulation of IFN-γ production and natural killer activity: lack of involvement of the Tac antigen to these immunoregulatory effects J. Immunol., 133, 779–83

    PubMed  CAS  Google Scholar 

  10. Fleit, H. B. and Rabinovitch. M. (1981). Production of interferon by in vivo derived bone marrow macrophages. Cell Immunol., 57, 495–504

    Article  PubMed  CAS  Google Scholar 

  11. Hannelore, J. and Deinhardt, F. (1983). Phenotype of human α-inteferon producing leucocytes unidentified by monoclonal antibodies. Clin. Exp. Immunol. 52. 179–84

    Google Scholar 

  12. Ronnblom, L., Ramstedt, U. and Alm, G. (1983). Properties of human natural interferon producing cells stimulated by tumour cell lines. Eur. J. Immunol., 13. 471–6

    Article  PubMed  CAS  Google Scholar 

  13. Torres, B. A., Farrar, W. L. and Johnson, H. M. (1982). Interleukin-2 regulates immune interferon (IFN-γ) production by normal and suppressor cell cultures. J. Immunol., 128. 2217

    PubMed  CAS  Google Scholar 

  14. Mizel, S. B. (1982). lnterleukin-1 and T-cell activation. Immunol. Rev., 63, 51–72

    Article  PubMed  CAS  Google Scholar 

  15. Torres, B. A., Yamamoto, J. K. and Johnson, H. M. (1982). Cellular regulation of gamma- interferon production by Lyt phenotype of the suppressor cell. Infect. Immun., 35. 770–6

    PubMed  CAS  Google Scholar 

  16. Unanue. E. R. (1984). Antigen presenting function of the macrophage. Ann. Rev. Immunol., 2, 395–428

    Article  CAS  Google Scholar 

  17. Farrar, W. L., Johnson, H. M. and Farrar, J. J. (1981). Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin-2. J. Immunol., 126, 1120–5

    PubMed  CAS  Google Scholar 

  18. Fellows, M., Malek, K., Gressor, I. and Bono, R. (1979). Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells. Eur. J. Immunol., 9, 446–9

    Article  Google Scholar 

  19. Blomgren. H., Strander. H. and Cantell, K. (1974). Effect of human leukocyte interferon on the response of lymphocytes to mitogenic stimuli. Scand. J. Immunol., 3, 697–704

    Article  PubMed  CAS  Google Scholar 

  20. Heron, I., Berg. K. and Cantell. K. (1976). Regulatory effect of interferon on T cells in vitro. J. Immunol., 117. 1370–3

    PubMed  CAS  Google Scholar 

  21. Herberman. R., Ortaldo, J. and Bonnard, G. (1979). Augmentation by interferon of human natural and antibody dependent cell-mediated cytotoxicity, Nature (London), 277. 221–3

    Article  CAS  Google Scholar 

  22. Abbud-Filho, M., Ransil, B. J., Kelley, V. F., Fiers, W. and Strom, T. B. (1986). Natural killer cell responses to interferon. Clin. Immunol. Immunolpathol., 39, 264–76.

    Article  CAS  Google Scholar 

  23. Pape, G. R., Hadam, M. R., Eisenburg, J. and Riethmuller, G. (1981). Kinetics of natural cytoxicity in patients treated with human fibroblast interferon. Cancer Immunol. Immunolher., 11, 1–6

    Google Scholar 

  24. Huddlestone, J. R., Merigan, T. C. and Oldstone. M. B. A. (1979). Induction and kinetics of natural killer cells in humans following interferon therapy. Nature (London), 282, 417–18

    Article  CAS  Google Scholar 

  25. Silva, A., Bonavida, B. and Targan, S. (1980). Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis. J. Immunol. 125. 479–83

    PubMed  CAS  Google Scholar 

  26. Wright, S. C. and Bonavida, B. (1983). III. Activation of NK cells by interferon augments the lytic activitv of released natural killer cytotoxic factors (NKCF). J. Immunol., 130, 2960–4

    PubMed  CAS  Google Scholar 

  27. Targan, S. R. and Newman. W. (1983). Definition of a ‘trigger’ stage in the NK cytotoxic reaction sequence by a monoclonal antibody to the glycoprotein T-200. J. Immunol., 131, 1149–53

    PubMed  CAS  Google Scholar 

  28. Grimm, E. A., Mazumder, A., Zhang, H. 2. and Rosenberg, S. A. (1982). Lymphokine activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumour cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med., 155, 1823–41

    CAS  Google Scholar 

  29. Weigent, D. A.. Stanton, G. I. and Johnson. H. M. (1983). Interleukin-2 enhances natural killer cell activity through induction of gamma interferon. Infect. Immun., 41, 992–7

    PubMed  CAS  Google Scholar 

  30. Sayers, T. J., Mason, A. T. and Ortaldo, J. R. (1986). Regulation of human natural killer cell activitv by interferon-gamma: lack of a role in interIeukin-2-mediated augmentation. J. Immunol., 136. 2176–80

    PubMed  CAS  Google Scholar 

  31. Dadmarz, R., Evans. T., Secher. D., Marshal, N. and Cawley. J. C. (1986). The mechanism of action of interferon-α (IFN-α) in hairy cell leukaemia; Hu-IFN-α2: receptor expression by hairy cells and other normal leukaemic cell types. Leuk. Res., 10, 1279–85

    Article  PubMed  CAS  Google Scholar 

  32. Paganelli, K. A., Evans, S. S., Han, T. and Ozer, H. (1986). B-cell growth factor-induced proliferation of hairy ccll lymphocytes and inhibition by type-1 interferon in vitro. Blood, 67, 937–42

    CAS  Google Scholar 

  33. Aoki, N. and Ohno, Y. (1987). Enhancement of the B-cell response to Staphylococcus aureus Cowan strain I by natural human gamma interferon. Immunology., 60, 51–5

    PubMed  CAS  Google Scholar 

  34. Peters. M., Ambrus. J. L.. Zheleznyak. A.. Walling, D. and Hoofnayle, J. H. (1986). Effect of interferon-α an immunoglobulin synthesis by human B cells. J. Immunol.. 137, 3153–7

    PubMed  CAS  Google Scholar 

  35. Weissenbach, J., Chernajousky, Y., Zeeui, M., Shulman, L., Soreq, H., Nir, U., Wallach. D., Perricaudet. M.. Tiollais. P. and Revel, M. (1980). Two interferon mRNA’s in human fibroblasts in vitro translation and Esherichia coli cloning studies. Proc. Natl. Acad. Sci. USA. 77. 7152–6

    Article  PubMed  CAS  Google Scholar 

  36. Billiau. A. (1986). BSF-2 is not just a differentiation factor. Nature (London). 324, 415

    Article  CAS  Google Scholar 

  37. Wallier, L., Guy. G.. Brown. G., Rowe, M., Milner, A. E. and Gordon. J. (1986). Control of human B-lymphocyte replication (1). Immunology, 58, 583–9

    Google Scholar 

  38. Bich-Thuy. L. and Fauci, A. S. (1986). Recombinant interleukin-2 and gamrna-inierferon act synergistically on distinct steps of in vitro terminal human B-cell maturation. J. Clin. Invest., 77. 1173–9

    Article  CAS  Google Scholar 

  39. Guyre. P. M., Morganclli, P. M. and Miller, R. (1983). Recombinant immune interferon increases immunoglobulin-G Fc rcccptors on cultured human mononuclear phagocytes. J. Clin. Invest., 72, 393–7

    Article  PubMed  CAS  Google Scholar 

  40. Esparza, I., Fox, R, I. and Schreiberr, D. (1986). lnterferon-γ dependent modulation of C3b receptors (CRI) on human peripheral blood monocytes. J. Immunol., 136. 1360–5

    PubMed  CAS  Google Scholar 

  41. Nathan. C. F.. Murray, H. W., Wiebe, M. E. and Rubin, B. Y. (1983). Identification of interferon-γ as the lymphokine that activated human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med., 158, 670–89

    Article  PubMed  CAS  Google Scholar 

  42. Wilson. C. B. and Westall, J. (1985). Activation of neonatal and adult human macrophages by alpha, beta, and gamma interferons. Infect. Immun., 49. 351–6

    PubMed  CAS  Google Scholar 

  43. Pace, J. I., Russell, S. W., Schreiber. R. D., Altman, A. and Katz, D H. (1983). Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-γ Proc. Natl Acad. Sci. USA. 80. 3782–6

    Article  PubMed  CAS  Google Scholar 

  44. Thurman, G. B., Braude, I. A., Gray, P. W., Oldham, R K. and Stevenson, H. C. (1985). MIF-like activity of natural and recombinant human interferon-y and their neutralization by monoclonal antibody. J. Immunol., 134. 305–9

    PubMed  CAS  Google Scholar 

  45. Rubinstein. M. and Orchansky. P. (1986). The interferon rcccptors. CRC Crit. Rev. Biochem., 21, 249–75

    Article  PubMed  CAS  Google Scholar 

  46. Orchansky. P., Rubinstein, M. and Fisher. D. G. (1986). The interferon-y receptor in human monocytes is different from the one in non-haemopoietic cells. J. Immunol., 136. 169–73

    PubMed  CAS  Google Scholar 

  47. Dadmarz. R., Evans. T., Secher. D., Marshall, N. and Cawley, J. C. (1987). Hairy cells possess more interferon receptors than other lymphoid cell types. Leukaemia, 1, 357–61

    CAS  Google Scholar 

  48. Billard. C., Sigaux. F., Castaigne, S., Valensi, F., Flandrin, G., Degos, L., Falcoff, E. and Aguet, M. (1986). Treatment of hairy cell leukaemia with IFN-α: In vivo down-regulation of IFN-α receptors on tumour cells. Blood, 67. 821–6

    PubMed  CAS  Google Scholar 

  49. Ebsworth. N., Taylor-Papadimitrion, J. and Rosengurt, E. (1984). Cyclic AMP does not mediate inhibition of DNA synthesis by interferon in mouse Swiss 3T3 cells. J. Cell Physiol., 120. 146–50

    Article  PubMed  CAS  Google Scholar 

  50. Tovey, M. G., Greser, I., Rochette-Egly, C., Begon-Lours-Guymarho, J., Bandu, M.T. and Maury, C. (1982). Indomethacin and aspirin do not inhibit the antiviral or antiproliferative actions of interferon. J. Gen. Virol., 63. 505–8

    Article  PubMed  CAS  Google Scholar 

  51. Yap, W. H., Teo. T. S., McCoy, E. and Tan, Y. H. (1986). Rapid and transient rise in diacylglycerol concentration in Daudi cells exposed to interferon. Proc. Natl Acad. Sci. USA, 83. 7765–9

    Article  PubMed  CAS  Google Scholar 

  52. Hamilton. T. A. Becton, D. L., Somers, S. D., Gray, P. W. and Adams, D. O. (1985). Interferon-γ modulates protein kinase C activity in murine peritoneal macrophages. J. Biol Chem., 260. 1378–81

    PubMed  CAS  Google Scholar 

  53. Mills, G. B., Hanger, G., Stewart. D.. Mellis. A., Williams. B and Gelford, F. W. (1985). IFNs do not signal cells through rapid alterations in phosphatidylinositide, hydrolysis, cytoplasmic free calcium or cytoplasmic alkalinisation. The 2-5A synthetase system: Molecular and clinical aspects of the interferon regulated pathway, pp. 357–67

    Google Scholar 

  54. Einat, M., Resnitsky, D. and Kimchi, A. (1985). Close link between reduction of c-myc expression by interferon and Go/G1 arrest. Nature, 313, 597–600

    Article  PubMed  CAS  Google Scholar 

  55. Knight, E., Anton, E. D., Fahey, D., Friedland, B. K. and Joual, G. J. (1985). Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc. Natl Acad. Sci. USA. 82. 1151–4

    Article  PubMed  CAS  Google Scholar 

  56. Resnitsky, D., Yarden. A., Zipori, D. and Kimchi. A. (1986). Autocrine β-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell. 46. 31–40

    Article  Google Scholar 

  57. Einat. M.. Resnitsky, D. and Kimchi. A. (1985). Inhibitory effects of interferon on the expression of genes regulated by platelet derived growth factor. Proc. Natl Acad. Sci. USA. 82. 7608–12

    Article  PubMed  CAS  Google Scholar 

  58. Kimchi, A. (1981). Increased levels of interferon induced (2’5’) oligoadenylate synthetase in mature T-lvmphocvtes and in differentiated Friend erythroleukaemic cells. J. Interferon Res., 1. 559–69

    Article  PubMed  CAS  Google Scholar 

  59. Billard, C, Ferbus. D., Kolb. J. P., Rosa, F., Perrot, J. Y., Merlin. G., Janiaud, P., Raynaud. N., Thang, M. N., Fellous, M., Aguet, M., Fridman, W. H. and Falcoff, R. (1986). Qualitative differences in effects of recombinant α, β, and γ IFNs on human peripheral blood leukocytes in vitro. Ann. Inst. Pasteur/Immunol., 137, 259–72

    Article  Google Scholar 

  60. Samuel, C., Duncan, R., Knutson, G. and Hershey, W. (1984), Mechanism of interferon action. J. Biol. Chem., 259, 13451–7

    PubMed  CAS  Google Scholar 

  61. Sreevalsan.T., Rosengurt, E.. Taylor-Papadimtrian, J. and Burchell, J. (1980). Differential effect of interferon on DNA synthesis. 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumour promoters. J. Cell. Physiol., 104. 1– 9

    Article  PubMed  CAS  Google Scholar 

  62. Silverman, R. H., Wattling, D., Balkivill, F. R., Trowsdal. J. and Kerr, I. M. (1982). The ppp(A2’p)nA and protein kinase systems in wild-type and interferon resistent Daudi cells. Eur. J. Biochem., 126, 333–41

    CAS  Google Scholar 

  63. Affabris, E., Jemma, C., Romeo. G. and Rossi, G. (1983). Biology of the Interferon System, pp. 201–6. ( Amsterdam: Elsevier )

    Google Scholar 

  64. Fellous. A., Ginsberg. I. and Littaucr, U. Z. (1982). Modulation of tubulin mRNA levels by interferon in human lymphoblastoid cells. EMBO. J., 7. 835–9

    Google Scholar 

  65. Worman, C. P., Catovsky, D., Bevan, P. C., Camba, L., Joyner, M., Green, P. J., Williams. H. J. H., Bottomley, J. M., Gordon-Smith. E. C. and Cawley, J. C. (1985). Interferon is effective in hairy-cell leukaemia. Br. J. Haematol., 60. 759–63

    Article  PubMed  CAS  Google Scholar 

  66. Golomb, H. M. (1987). The treatment of hairy cell leukaemia. Blood. 69. 979 - 83

    PubMed  CAS  Google Scholar 

  67. Lehn, P., Sigaux, F., Grausz, D., Loiseau, P., Castaigne. S., Degos, L., Flandrin, G. and Dautry, F. (1986). C-myc and c-fos expression during IFN-α therapy for hairy-cell leukaemia. Blood, 68, 967–70

    PubMed  CAS  Google Scholar 

  68. Merz, B. (1986). Interferon’s track record: good in hairy-cell leukaemia, fair in other haematologic cancers, poor in solid tumours. J. Am. Med. Assoc., 256. 1242–4

    Article  CAS  Google Scholar 

  69. Foon, K. and Sherwin, S. A. (1984). Treatment of advanced non-Hodgkins lymphoma with recombinant IFN-α., N. Engl. J. Med., 311. 1148–52

    Article  PubMed  CAS  Google Scholar 

  70. O’Connell, M. J., Colger, J., Oken, N., Pitts, R., Key, N. and Itri, L. (1986). Clinical trial of rIFX-α as initial therapy for favourable non-Hodgkins lymphomas and CLL. J. Clin. Oncol., 4

    Google Scholar 

  71. Bunn. P. A., Foon, K. A. and Ibide, D. (1984). Recombinant leukocyte A interferon: an active agent in advanced T-cell lymphomas. Ann. Intern. Med., 101, 484–7

    PubMed  Google Scholar 

  72. Roth. M. S. and Foon, K. A. (1986). Alpha-interferon in the treatment of hematologic malignancies. Am. J. Med., 81. 871–82

    Article  PubMed  CAS  Google Scholar 

  73. Talpaz, M., Kantarjian, H. M., McCredie, K., Trujillo, J. M., Keating, M. J. and Gutterman, J. U. (1986). Hematologic remission and cytogenic improvement induced by recombinant human interleron-α in chronic myelogenous leukemia. N. Engl. J. Med., 314, 1065–9

    Article  PubMed  CAS  Google Scholar 

  74. Talpaz, M., Trujillo, J. M., Hittelman, W. N., Keating, M. J. and Gutterman, J. U. (1985). Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leukocyte interferon. Br. J. Haematol., 60, 619–24

    Article  PubMed  CAS  Google Scholar 

  75. Ahre, A., Bjorkholm, M. and Mellstedt, H. (1984). Human leukocyte interferon and intermittent high dose melphalan-prednisolone administration in the treatment of multiple myeloma a randomised clinical trial from the myeloma group of central Sweden. Cancer Treat. Rep., 68. 1331–8

    PubMed  CAS  Google Scholar 

  76. Quesada, J. R., Alexanian, R., Hawkins, M., Barlogie, B., Borden, E., Itri, L. and Gutterman, J. U. (1986). Treatment of multiple myeloma with recombinant α IFN. Blood, 67, 275–8

    PubMed  CAS  Google Scholar 

  77. Clark, R., Dimitrou, N. V., Axelson, J. A. and Charamella, L. J. (1984). Leucocyte IFN as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapy. J. Biol. Reap. Mod., 3, 613–19

    CAS  Google Scholar 

  78. Foon, K., Bottino, G. and Abrams, P. (1985). Phase II trial of recombinant leukocyte A IFN in advanced chronic lymphatic leukaemia. Am. J. Med., 78. 216–20

    Article  PubMed  CAS  Google Scholar 

  79. Dadmarz, R. and Cawley, J. C. (1987). Heterogeneity of CLL: low CD23 antigen and IFNα receptor expression are features of advanced disease, (in press).

    Google Scholar 

  80. Krown, S., Real, F. X., Cunningham-Rundles. S., Myskowski, P., Koziner. B., Fein, S., Mittleman, A., Oettgen. H. and Safai, B. (1983). Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual man with Kaposi’s sarcoma. N. Engl. J. Med., 308, 1071–6

    Article  PubMed  CAS  Google Scholar 

  81. Vadhan-Raj, S., Wong, G., Grecco, C., Cunningham-Rundles, S., Krim, M., Real, F. X., Oettgen, H. F. and Krown, S. E. (1986). Immunological variables as predictors of prognosis in patients with Kaposi’s sarcoma and the acquired immunodeficiency syndrome Cancer Res., 46, 417–25

    PubMed  CAS  Google Scholar 

  82. Real, F. X., Oettgen, H. and Krown, S. (1986). Kaposi’s sarcoma and AIDS treated with high and low dose recombinant αIFN-A. J. Clin. Oncol., 4. 544–51

    PubMed  CAS  Google Scholar 

  83. Kirkwood. J. M., Ernstoff. M. S. and Davis, C. A. (1985). Comparison of intramuscular and intravenous recombinant α-2 interferon in melanoma and other cancers. Ann. Intern. Med., 103. 32–6

    PubMed  CAS  Google Scholar 

  84. Dorval. T., Palangie, T., Jouve, M., Garcia-Giralt, E., Israel, L., Falcoff, E., Schurab, D. and Pouillart, D. (1986). Clinical Phase II trial of recombinant DNA interferon α2b in patients with metastatic malignant melanoma. Cancer, 58, 215–18

    PubMed  CAS  Google Scholar 

  85. Kuzmits, R., Kokoschka, G. M., Micksche, M., Ludwig, H. and Flener, R. (1985). Phase II results with recombinant interferon: renal cell carcinoma and malignant melanoma. Oncology, 42 (suppl. I), 26–32

    Article  PubMed  Google Scholar 

  86. Erikson, B., Oberg, K., Alm, G., Karlsson, A., Lundquist, G., Anderson, T., Wzlandr, E. and Wide, L. (1986). Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon. Lancet, 2, 1307–8

    Article  Google Scholar 

  87. Ikic, D., Krusic, J., Kirkmajer, V., Knezevic, M., Marcic, Z., Rode, B., Jusic, D. and Soos. E. (1981). Application of human leucocyte interferon in patients with carcinoma of the uterine cervix. Lancet, 1, 1027–30

    Article  PubMed  CAS  Google Scholar 

  88. Seto, W. H., Choo, Y. C., Merigan, T. C., Tan, C. and Ng, M. (1983). Local interferon-α treatment of intraepithelial neoplasia. Antiviral research- the biology of the IFN system, p. 34

    Google Scholar 

  89. McCabe. B. F. and Clark. K. F. (1983). Interferon-α and laryngeal papillomatosis. Ann. Otol. Rhin. Laryngol., 92, 2–7

    CAS  Google Scholar 

  90. Gall, S. A., Hughes, C. E. and Trofatter. K. (1983). Interferon for therapy of condylomata acuminata. Ann. J. Obstet. Gynecol., 153, 157–63

    Google Scholar 

  91. Eron, L. J., Judson, F. and Tucker, S. (1986). Interferon therapy for condylomata acuminata. N. Engl J. Med., 315, 1059–64

    Article  PubMed  CAS  Google Scholar 

  92. Gregorv, P. B. (1986). Interferon-α in chronic active hepatitis B. Gastroenterology. 90. 237–40

    Google Scholar 

  93. Dooley, J. S., Davis, G., Peters, M., Wagener, J., Goodman, Z. and Houghnagel, J. (1986). Pilot study of rIFN-α in chronic hepatitis B. Gastroenterology, 90, 150–7

    PubMed  CAS  Google Scholar 

  94. Thomason, B. J., Doran, M., Lever, A. M. L. and Webster, A. D. B (1987). αIFN therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapv. Lancet, 1, 539–41

    Article  Google Scholar 

  95. Gelman, E. P., Preble, O. T., Steis. R., Lome, H. C., Rooh, A. H., Wesley, M., Jacob, J., Fanci, A., Masur, H. and Longo, D. (1985). Human lymphoblastoid interferon treatment of Kaposi’s sarcoma in the acquired immune deficiency syndrome. Am. J. Med., 78, 737–41

    Article  Google Scholar 

  96. Douglas. R. G. (1986). The common cold-relief at last? N. Engl. J. Med., 314, 114–15

    Article  PubMed  Google Scholar 

  97. Kurzrock, R., Quesada, J., Talpaz, M., Hersh, E., Reuben, J., Sherwin, S. and Gutterman, J. (1986). Phase I study of multiple dose recombinant IFN-γ. J. Clin. Oncol., 4, 1101–9

    PubMed  CAS  Google Scholar 

  98. Kurzrock, R., Quesada, J., Talpaz, M., Hersh, E., Reuben, J., Sherwin, S. and Gutterman, J. (1986). Phase I study of combination or recombinant IFN-α and IFN-γ in cancer patients. J. Clin, Oncol., 4, 1677–83

    CAS  Google Scholar 

  99. Quesada, J., Talpaz, M., Rios, A., Kurzock, R. and Gutterman, J. (1986). Clinical toxicity of interferons in cancer patients: A review. J. Clin. Oncol., 4, 234–43

    PubMed  CAS  Google Scholar 

  100. Verma, D. G., Spizer, G., Gutterman, J. and Zamder. A. (1979). Human leukocyte interferon preparation blocks granulopoietic differentiation. Blood, 54. 1423–7

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. D. Griffiths
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. W. Galvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. C. Cawley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Royal Victoria Hospital, Bournemouth, UK

    T. J. Hamblin

  2. Department of Haematology, Royal Victoria Hospital, Shelley Road, Boscombe Bournemouth, BH1 4JG, UK

    T. J. Hamblin

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Griffiths, S.D., Galvani, D.W., Cawley, J.C. (1989). The Interferons. In: Hamblin, T.J. (eds) Immunotherapy of Disease. Immunology and Medicine Series, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1844-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1844-3_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7322-6

  • Online ISBN: 978-94-009-1844-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation